Optical Surface Monitoring Technology-Guided Large-Segment Radiotherapy for Breast Cancer

This study is a single-center,blinded, efficacious, phase III randomized clinical trial initiated by investigators. The primary objective is to investigate the use of Surface Guided Radiation Therapy (SGRT) in combination with Deep Inspiration Breath Hold (DIBH) technique for left breast cancer treatment, compared to traditional laser alignment with free breathing treatment. This approach offers superior positioning accuracy and improved heart protection without any increase in radiation or adverse reactions.

Trial Details

NCT ID

NCT05804916

Phase

PHASE2 / PHASE3

Sponsor

Peking Union Medical College Hospital

Status

RECRUITING

Cancer Type

Breast Cancer

Interventions

Surface Guided Radiation Therapy (SGRT)

Locations (sample)

Beijing, Beijing Municipality, China|39.9075,116.39723

Key Eligibility Criteria

Patients who have undergone breast-conserving surgery or modified radical mastectomy for left breast cancer;
Planned whole-breast ± supraclavicular region, chest wall ± supraclavicular region radiotherapy;
Able to perform deep inspiration breath-hold technique with breath-holding time \>35s and can repeat it continuously for more than 6 times;
Patients who have not received neoadjuvant chemotherapy or breast reconstruction surgery;

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →